In cleanroom environments, the battle against microbial contamination is constant and evolving.
Facilities across various industries, from pharmaceutical manufacturing to research areas, are always looking for effective biodecontamination methods.
However, selecting an effective method includes several challenges: uneven coverage, damage to sensitive equipment and the looming shadow of regulatory non-compliance. These problems risk the integrity of sterilization processes and pose significant operational and safety concerns.
These challenges are further compounded by the array of biodecontamination technologies available, each with its limitations. Traditional methods, such as atomizing and fogging, though widespread, often struggle with controlling droplet size and distribution, leading to inconsistent biodecontamination.
Enter VHP, a game-changing technology in biodecontamination.
In this article, we delve into a comprehensive comparison between VHP and other prevalent biodecontamination technologies, focusing on regulatory compliance and validation of the technique.
Regulatory Compliance and Efficacy of VHP
One of the key reasons VHP is preferred in life sciences and current Good Manufacturing Practices (cGMP) industries is its comprehensive regulatory compliance.
Disinfectants and sporicides like VHP are registered under the United States Environmental Protection Agency (EPA) and the European Chemicals Agency (ECHA).
These methods have created a robust baseline for efficacy and a long history of product registrations.
For technologies like vaporization, fogging or atomizing to gain registration, the chemistry must be tested specifically with the applicator or device used in the process. Any claims made must be valid for the specific application method.
VHP stands out, as it is a registered sporicidal process approved by the EPA (Registration No. 58779-4) and the European Chemicals Agency (ECHA) under the Biocidal Products Regulation (BPR) No. 528/2012. VHP is also routinely accepted on a global basis as a validated sporicidal process for cGMP operations.
The VHP process, including the liquid hydrogen peroxide solution and VHP Biodecontamination Units, has undergone rigorous testing under these regulatory guidelines, demonstrating its antimicrobial efficacy against a diverse range of organisms, including bacterial spores.
Validation of VHP: Ensuring Consistency and Effectiveness
When it comes to validation, VHP's technological superiority becomes even more apparent.
Validation of any biodecontamination technology or process demands repeatability and reproducibility.
VHP Biodecontamination Units are engineered to deliver a consistent and repeatable hydrogen peroxide injection rate and airflow, resulting in a uniform vapor concentration throughout the biodecontamination process.
This precision is especially vital compared to the challenges posed by fogging or atomization technologies, where ensuring that the product in its “fog form” accurately represents the liquid product can be difficult.
VHP is validatable and employs a combination of indicators and sensors during its validation process.
Chemical indicators (CI) demonstrate distribution and coverage within a room or enclosure, changing color based on the concentration level and exposure time to VHP.
This is complemented by continuous process monitoring, which is essential for ensuring the safety and efficacy of the sporicide during use. VHP can be monitored using hydrogen peroxide sensors, which only detect the vapor form, thereby ensuring the accuracy of the process.
Biological indicators (BIs) are used to demonstrate activity against challenging organisms.
The typical VHP BI involves a 6-log Geobacillus stearothermophilis spore inoculated on a stainless-steel or polymer disk wrapped in Tyvek®, which facilitates handling, prevents surface contamination and acts as a barrier exclusively permeable to vapor.
This validation approach has been successfully implemented globally in numerous applications, including rooms, isolators, biosafety cabinets and chambers.
Elevating Biodecontamination Standards: The VHP Advantage
VHP emerges as a viable alternative in the field of biodecontamination due to its regulatory compliance and robust validation processes.
Its ability to consistently deliver effective antimicrobial action, coupled with the backing of regulatory authorities like the EPA and ECHA, makes it a preferred choice for critical applications in life sciences and other industries requiring stringent microbial control.
The precision and reliability of the VHP process set it apart, ensuring compliance and effectiveness in biodecontamination efforts.
